<?xml version=“1.0” encoding=“UTF-8”?> <MedicinalProductIndication xmlns=“hl7.org/fhir”>

<id value="example"/>
  <meta>
  <security>
    <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/>
    <code value="HTEST"/>
    <display value="test health data"/>
  </security>
</meta>
<diseaseSymptomProcedure>
    <coding>
      <system value="http://ema.europa.eu/example/indicationasdisease-symptom-procedure"/>
      <code value="Venousthromboembolismprophylaxis"/>
    </coding>
    <text value="Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\nor knee replacement surgery.\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients)."/>
  </diseaseSymptomProcedure>
  <comorbidity>
    <coding>
      <system value="http://ema.europa.eu/example/comorbidity"/>
      <code value="Hipsurgery"/>
    </coding>
  </comorbidity>
  <intendedEffect>
    <coding>
      <system value="http://ema.europa.eu/example/intendedeffect"/>
      <code value="PRYLX"/>
    </coding>
  </intendedEffect>
  <population>
    <ageRange>
      <low>
        <value value="18"/>
        <unit value="a"/>
      </low>
    </ageRange>
  </population>

</MedicinalProductIndication>